Stockholders’ Deficit |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| Stockholders’ Deficit | Note 4 – Stockholders’ Deficit
As of December 31, 2025 and 2024, the Company had 280,000,000 authorized shares of common stock, consisting of (i) 240,000,000 shares of Class A common stock, $0.001 par value per share, and (ii) 40,000,000 shares of Class B common stock, $0.001 par value per share. The holders of Class A common stock and Class B common stock vote together as a single class on all matters, including the election of directors.
Class A Common Stock
As of December 31, 2025, and 2024, the Company had 114,898,024 and 114,348,024 shares, respectively, of Class A common stock issued and outstanding. Each share of Class A common stock has one vote per share.
Class B Common Stock
As of December 31, 2025, and 2024, the Company had 40,000,000 shares of Class B common stock issued and outstanding. Each share of Class B common stock has 50 votes per share.
Shares issued in offering
On January 28, 2025, the Company entered into securities purchase agreements with an investor, pursuant to which the Company agreed to sell and issue an aggregate of 550,000 shares of Class A common stock at a purchase price of $2.00 per share for aggregate proceeds to the Company of $1,100,000.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|